0000315066-15-003307.txt : 20151117 0000315066-15-003307.hdr.sgml : 20151117 20151117135714 ACCESSION NUMBER: 0000315066-15-003307 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151113 FILED AS OF DATE: 20151117 DATE AS OF CHANGE: 20151117 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Blueprint Medicines Corp CENTRAL INDEX KEY: 0001597264 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 38 SIDNEY STREET, SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-374-7580 MAIL ADDRESS: STREET 1: 38 SIDNEY STREET, SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FMR LLC CENTRAL INDEX KEY: 0000315066 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37359 FILM NUMBER: 151237838 BUSINESS ADDRESS: STREET 1: 245 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6175706339 MAIL ADDRESS: STREET 1: 245 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02210 FORMER NAME: FORMER CONFORMED NAME: FMR CORP DATE OF NAME CHANGE: 19920717 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2015-11-13 0 0001597264 Blueprint Medicines Corp BPMC 0000315066 FMR LLC 245 SUMMER STREET BOSTON MA 02210 0 0 1 1 See Remark 1 Common Stock 2015-11-13 4 J 0 1204280 0 D 1296431 I See Footnote 1 Common Stock 2015-11-13 4 G 0 68628 0 D 1227803 I Shares held by persons and entities whose shares are subject to reporting by the undersigned. Common Stock 2015-11-13 4 G 0 4567 0 D 1223236 I Shares held by persons and entities whose shares are subject to reporting by the undersigned. Common Stock 2015-11-13 4 G 0 25955 0 D 1197281 I Shares held by persons and entities whose shares are subject to reporting by the undersigned. Beacon Bioventures Fund III Limited Partnership made a pro-rata distribution to its partners, without payment of consideration, of 2,313,158 shares of Blueprint Medicines Corp. previously reported by FMR LLC. Beacon Bioventures Fund III Limited Partnership distributed 1,492,158 shares to Impresa Fund III Limited Partnership (IFLP), 17,441 shares to Beacon Bioventures Advisors Fund III Limited Partnership (BBAF) and 803,559 shares to a recipient whose shares are not subject to reporting by the undersigned (an Other Recipient). BBAF made a pro-rata distribution to its partners, without payment of consideration, of 2,205 shares to F-Prime Inc. and 15,236 shares to Other Recipients. IFLP made a pro-rata distribution to its partners, without payment of consideration, of 385,485 shares to Other Recipients and 1,031,533 shares to persons and entities whose shares are subject to reporting by the undersigned. Remark 1: Edward C. Johnson 3d is a Director and the Chairman of FMR LLC and Abigail P. Johnson is a Director, the Vice Chairman, the Chief Executive Officer and the President of FMR LLC. Members of the family of Edward C. Johnson 3d, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders' voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. The address of Edward C. Johnson 3d and Abigail P. Johnson is c/o FMR LLC, 245 Summer Street, Boston, MA 02110. Remark 2: The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the undersigned are the beneficial owners of any securities reported herein. Marc R. Bryant, Duly authorized under Powers of Attorney, by and on behalf of FMR LLC and its direct and indirect subsidiaries, Edward C. Johnson 3d and Abigail P. Johnson 2015-11-17